Home » Authors » Amanda Pedersen

Articles by Amanda Pedersen

Orthovita prices 7.7M shares at $3.25/share; plans to buy Vitagel

Nov. 20, 2006

By Amanda Pedersen

Deals roundup: Reflect set to gorge on merger agreements as growth strategy

Nov. 17, 2006

By Amanda Pedersen

FDA approves Latitude system with EMR data integration

Nov. 16, 2006

By Amanda Pedersen

WorldHeart to cut workforce; gets $14 million from investors

Nov. 15, 2006

By Amanda Pedersen

FDA approves Latitude system with EMR data integration

Nov. 15, 2006

By Amanda Pedersen

Transcend, out of ForSight Labs, gathers in Series A $7 million

Nov. 10, 2006

By Amanda Pedersen

Tug-of-war heats up as cuts to doctors nears Jan. 1 deadline

Nov. 9, 2006

By Amanda Pedersen

Web-based tool a longer-range assay for breast cancer risk

Nov. 9, 2006

By Amanda Pedersen

Web-based tool a longer-range tool for breast cancer risk

Nov. 8, 2006

By Amanda Pedersen

Boston Scientific and EndoTex move closer to sealing merger

Nov. 7, 2006

By Amanda Pedersen

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...